What caused the B8F.DE stock surge on 11 Mar 2026?

The surge was driven by a large volume spike of **45,797** shares on XETRA, paired with thin average daily volume. Low float and targeted trading, plus news-linked market interest, amplified the move.

What is Meyka AI's view and forecast for B8F.DE stock?

Meyka AI rates B8F.DE **62.66/100 (B, HOLD)**. Meyka AI's forecast model projects a **€8.50** 12-month target, implying **24.93%** upside from **€6.80**. Forecasts are model-based and not guarantees.

Are fundamentals supportive for B8F.DE stock investment?

Fundamentals show negative EPS **-0.21** and a trailing PE of **-32.40**, but P/S **0.64** and EV/sales **0.58** suggest valuation is modest. Ongoing losses and liquidity risk remain material downsides.

How should traders manage risk on B8F.DE trading?

Use small position sizes, set tight stop losses, and prepare for wide spreads. Given the stock’s average volume **605.00**, today's **45,797** print was atypical and can reverse quickly.

DE Stocks

High volume lifts B8F.DE Biofrontera AG XETRA to €6.80 on 11 Mar 2026: key outlook

ByHuzaifa Zahoor March 12, 2026

B8F.DE stock jumped to €6.80 on XETRA on 11 Mar 2026 after an extraordinary volume surge of 45,797 shares. The move lifted the intraday high to €6.80 from an open of €0.37, pushing price well above the 50-day average of €6.53. Traders cited thin free float and newsflow-linked trading as drivers. We break down fundamentals, liquidity, Meyka AI’s grade and a model-based price forecast to explain whether this high-volume move is sustainable.